ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

207. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summaryfor 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783?805.208. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstreaminfections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. ClinInfect Dis 2004; 39:309?17.209. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis2005; 41:848?54.210. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureuscentral line-associated bloodstream infections in US intensive care units, 1997?2007. JAMA 2009;301:727?36.211. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short- termcentral venous catheters. Intensive Care Med 2004; 30:62?7.212. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheterrelatedinfection. N Engl J Med 1977; 296:1305?9.213. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis ofindwelling vascular catheters: a quantitative relationship between luminal colonization and duration ofplacement. JInfect Dis 1993; 168:400?7.214. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. DNA fingerprinting analysis of coagulase negativestaphylococci implicated in catheter related bloodstream infections. J Clin Pathol 2002; 55:824?8.215. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenousseeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995; 14:134?7.216. Raad I, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: is it safeto prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001; 22:136?9.217. Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath enhances central venous catheter infection.Crit Care Med 2002; 30:908?12.218. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. ClinMicrobiol Rev 2002; 15:167?93.219. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro.Infect Immun 1994; 62: 915?21.220. Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology of catheter-associated sepsis. Correlation withthrombogenicity. Arch Surg 1977; 112:1497?9.221. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic andinfectious complications of central venous catheters. JAMA 1994; 271:1014?6.222. Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcusaureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991; 59:279?88.223. Shanks RM, Sargent JL, Martinez RM, Graber ML, O’Toole GA. Catheter lock solutions influencestaphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21:2247?55.224. Chatzinikolaou I, Zipf TF, Hanna H, et al. Minocycline-ethylenediaminetetraacetate lock solution for theprevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36:116?9.225. McDevitt D, Francois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surfacelocatedfibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 1995; 16:895?907.226. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ. Clumping factor B (ClfB), a new surfacelocatedfibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 1998; 30:245?57.60